Jul. 13, 2011 (Canada NewsWire Group) --
HALIFAX, July 13, 2011 /CNW/ - MedMira Inc., ("MedMira") (TSXV: MIR) (NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, today announced that it has completed and shipped the order for 400,000 rapid HIV tests placed by its strategic partner in China, Triplex International Biosciences Co., Ltd. (Triplex), in April 2011.
"The fulfillment of this initial order for Triplex went very smoothly," said Hermes Chan, CEO, MedMira Inc. "The Triplex sales strategy in the new China healthcare sector is working very well, with the number one ranking of our test in a recent evaluation by the China National Center for Disease Control (China CDC) being a key marketing tool in many of their initiatives."
Triplex has placed a follow-on order for MedMira rapid HIV tests as it continues to pursue sales opportunities in the outreach clinics and hospital laboratory vertical markets in the high growth rapid diagnostics market within China's restructured healthcare system.
Maybe since its been a year we will see that follow up order around the same time of year.??